PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
PURE BIOSCIENCE, INC.
Financials through Q3 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 15, 2026
$0.07−0.01 (-12.10%)
Close on Oct 19, 2026
- Market cap
- $7.33M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0099 (−13.03%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
PURE BIOSCIENCE, INC. grew revenue 26.8% to $2.42M over the twelve months to Apr 30, 2026.
Revenue
$2.42M
+26.8% vs. a year earlier
Operating income
-$1.92M
TTM Q3 2026
EPS, diluted
-$0.02
TTM Q3 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Apr 30, 2026
Valuation
- Market cap
- $7.33M
- P/E ratio
- –
- Price to sales
- 3.03
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $2.42M
- Net income
- -$2.21M
- EPS, diluted
- -$0.02
- Book value per share
- -$0.05
- Diluted shares
- 111M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$2.42M+26.8% YoY
Gross profit
$1.43M+28.4% YoY
Operating income
-$1.92M
Net income
-$2.21M
EPS, diluted
-$0.02
Free cash flow
–
Reported periodTrailing twelve months